Mitochondrial wellness

Haemolysed blood sample: What now?

Understand a haemolysed blood sample, why potassium results may need review, and which blood test questions to ask your healthcare team before another sample.

Dr Dooa Arif, mescreen™ UK science writer

Written by

Reviewed by Hemal Patel, PhD

Illustrative empty laboratory tube and closed transport box, not a real specimen or mescreen™ equipment

TL;DR: A haemolysed blood sample contains broken-down red blood cells, which can affect testing; ask the team reviewing your report which results remain usable and what happens next (Harrogate NHS definition, Southampton NHS specimen policy).

Key takeaways

What does a haemolysed blood sample mean?

A haemolysed blood sample is one in which red blood cells have broken down and released their contents into the surrounding fluid. Harrogate's NHS quality-improvement summary defines haemolysis as the rupture of red blood cells.

That definition describes something about the specimen; this article cannot establish why it happened in your case.

If the word appears beside a result, the useful question is what the laboratory means by that comment for the particular test. A technical label is not obliged to explain itself. Apparently that would be far too convenient.

Illustrative notebook and telephone in a warm home study for a follow-up conversation, not a patient story

Why can haemolysis change a test result?

Material released from damaged cells can affect the measurement being reported. A concrete example is potassium: North Bristol NHS Trust's laboratory page states that sample haemolysis can cause an artefactually raised result, meaning a rise created by a testing-related effect rather than a straightforward reflection of the intended measurement.

That example does not mean every test is affected in the same way. Southampton's specimen policy lists haemolysis affecting tests among its rejection reasons and describes different reporting arrangements for different laboratory areas.

Do not dismiss a high potassium result as sample damage yourself. Follow any instructions from the healthcare team, including urgent instructions, and ask them to explain the laboratory comment. This article cannot decide whether a reported result is safe to disregard.

Does the comment tell you what caused it?

The comment alone does not give this article enough information to identify the cause. Harrogate's summary describes multiple reasons for haemolysed samples, including some that may be unavoidable, and discusses collection practice as one area for improvement.

It would therefore be inappropriate to blame the person giving the sample, assume a collection error or infer a diagnosis from the word alone. The team handling the sample and reviewing the report has the relevant case information.

Our suggested question is precise: does this comment concern the quality of this specimen, and does the healthcare professional need to investigate anything further? That separates two questions instead of asking one laboratory word to run the whole meeting.

Why might a result be missing rather than flagged?

A result may be withheld when the specimen is unsuitable for the requested analysis. Southampton's published procedure says unsuitable specimens must be rejected to avoid producing misleading results and describes recording a laboratory comment for haemolysed coagulation samples.

Abstract separated glass cube and coral sphere, not a biological diagram, test result or clinical evidence

This is an example of a local laboratory procedure, not a promise about how every UK report looks. The absence of a number and the presence of a number with a comment are different situations to clarify with the reporting team.

Ask whether a particular measurement was not reported, whether a reported measurement carries a limitation, or whether the whole specimen could not be used. Do not assume that every line on the report has the same status.

What should you ask before another sample?

Ask the team arranging the test to confirm whether another sample is needed and give the instructions for that appointment or kit. NHS guidance says the GP, nurse or specialist should explain any preparation required and that unclear results should be discussed with a healthcare professional.

Our suggested follow-up checklist is:

  • Which test or result is affected by the comment?
  • Which results, if any, can still be interpreted?
  • Is another sample required, and who is arranging it?
  • What timing and preparation instructions apply to that specific test?
  • Who should explain the completed report and any next steps?

These are questions, not a recommendation to repeat a test yourself. This article does not advise changes to medicines, supplements, food, fluid intake or exercise. More enthusiastic preparation is not a substitute for the correct instructions.

Illustrative empty clinic waiting area, not mescreen™ premises or a claim that it provides consultations

Does this apply to mescreen™'s dried blood spots?

The cited hospital guidance does not establish the acceptance criteria for mescreen™'s dried blood spot method. mescreen™'s current UK process page describes collection on a dried blood spot card, laboratory quality checks and a wellness and functional laboratory assessment.

That is a different product context from the serum potassium and coagulation examples above. Those examples cannot establish how a mescreen™ specimen is assessed, which measurements might be affected or whether a repeat is appropriate.

The same mescreen™ intended-use wording states that its report is not a diagnosis, a substitute for NHS blood tests or a reason to delay care. No source cited here demonstrates that mescreen™ diagnoses haemolysis, measures potassium or improves clinical outcomes.

For a mescreen™ sample query, contact the service for its own explanation and instructions. Our blood-test turnaround article offers related reading about the stages between collection and reporting, not evidence about your sample.

Limitations

This is general information, not a diagnosis, personal result interpretation or collection protocol. It cannot determine why a sample was haemolysed, which of your results is reliable or whether you need a repeat test.

The Harrogate document is a historical quality-improvement summary used for its definition, not for current national failure rates. Southampton's document describes a local procedure, while North Bristol's example concerns serum potassium. None supplies universal thresholds for all tests or MeScreen-specific validation.

The generated images are illustrative settings and objects. They are not real specimens, patient stories, mescreen™ equipment or evidence that mescreen™ provides clinical consultations.

Illustrative sealed mailer and blank instruction booklet at home, not actual mescreen™ kit contents or sampling guidance

What is the next sensible step?

Ask the healthcare professional reviewing the result to explain the exact comment and the agreed follow-up, as the NHS advises for unclear blood-test results. Keep any medical follow-up separate from an enquiry about a wellness service.

A useful answer should tell you what was affected, what remains known and who is doing what next. That is more helpful than trying to diagnose the meaning of an unfamiliar word on your own.

Sources